Iteos Therapeutics Inc (ITOS)

$10.72 0.27 (2.46%)

12:50 EDT ITOS Stock Quote Delayed 30 Minutes

ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q4 2023

By InvestorPlace Earnings Mar 6, 2024

ITOS stock results show that ITeos Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

The 7 Most Undervalued Stocks You Need to Know About

7 Small-Cap Stocks That Are Flying Under the Radar

More Articles

Volume:

Previous Close -

Market Cap 383.39M

PE Ratio -24.36

EPS -0.44

Volume (Avg. Vol.) 46,846

Day's Range $10.66 - $11.22

52-Week Range $8.20 - $17.93

Dividend & Yield N/A (N/A)

ITOS Stock Predictions, Articles, and Iteos Therapeutics Inc News

From InvestorPlace
From the Web

7 Dirt-Cheap Stocks Sitting in the Sweet Spot

By Josh Enomoto, InvestorPlace Contributor Mar 23, 2023

These cheap stocks don’t just attract on the ticker tape but rather feature compelling fundamentals and analysts’ upside projections.

The Top 7 Growth Stocks in Biotech

By Alex Sirois, InvestorPlace Contributor Mar 3, 2023

The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.

The 7 Best Biotech Stocks to Buy for February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 7, 2023

Following the wave of red ink last year, astute investors should target the best biotech stocks to buy this month for strong growth potential.

The 7 Most Undervalued Biotech Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 2, 2023

Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

7 Top-Rated Biotech Stocks to Buy for Q2

By Louis Navellier and the InvestorPlace Research Staff Apr 21, 2022

In these tumultous economic times, look to sectors that are outside the turmoil. Each of these seven biotech stocks fit the bill.

(NASDAQ:ITOS)

From Seeking Alpha May 10, 2023

iTeos Therapeutics press release (ITOS): Q1 GAAP EPS of -$0.44. The company’s cash, cash equivalents, and investments position was $706.6 million as of March 31, 2023, as compared...

(NASDAQ:ITOS)

From Seeking Alpha Mar 15, 2023

iTeos Therapeutics press release (ITOS): Q4 GAAP EPS of $0.54.The Company’s cash, cash equivalents and investments position was $731.4 million as of December 31, 2022, as compared...

RCUS stock, ITOS stock fall as Roche comments on anti-TIGIT cancer trial (NASDAQ:ITOS)

From Seeking Alpha Feb 2, 2023

iTeos Therapeutics (ITOS) and Arcus Biosciences (RCUS) fell pre-market trading Thursday after Roche (RHHBY) (RHHBF) CEO commented on its anti-TIGIT immunotherapy. Read the full story here.

Analysts Offer Insights on Healthcare Companies: iTeos Therapeutics (ITOS), Verona Pharma (VRNA) and vTv Therapeutics (VTVT)

From TipRanks Nov 14, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on iTeos Therapeutics (

iTeos Therapeutics GAAP EPS of $0.03 (NASDAQ:ITOS)

From Seeking Alpha Nov 10, 2022

iTeos Therapeutics press release (ITOS): Q3 GAAP EPS of $0.03.The company’s cash and cash equivalent position was $752.2 million as of September 30, 2022, as compared to $899.8 million...

H.C. Wainwright Keeps Their Buy Rating on iTeos Therapeutics (ITOS)

From TipRanks Aug 12, 2022

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on iTeos Therapeutics (ITOS – Research Report), with a price t...

ADVERTISEMENT